Abstract
Children with acute myeloid leukemia (AML) and Down syndrome have high survival rates with intensity-reduced chemotherapeutic regimens, although the optimal balance between dose intensity and treatment toxicity has not been determined. We, therefore, characterized infectious complications in children with AML and Down syndrome treated according to AML-BFM 2004 study (ClinicalTrials.gov NCT00111345; amended 2006 for Down syndrome with reduced intensity). Data on infectious complications were gathered from the medical records in the hospital where the patient was treated. Infectious complications were categorized as fever without identifiable source (FUO), or as microbiologically or clinically documented infections. A total of 157 infections occurred in 61 patients (60.5% FUO, 9.6% and 29.9% clinically and microbiologically documented infections, respectively). Almost 90% of the pathogens isolated from the bloodstream were Gram-positive bacteria, and approximately half of them were viridans group streptococci. All seven microbiologically documented episodes of pneumonia were caused by viruses. Infection-related mortality was 4.9%, and all three patients died due to viral infection. Our data demonstrate that a reduced-intensity ch...Continue Reading
References
Aug 1, 1984·The Journal of Pediatrics·L L RobisonD Hammond
Jul 4, 1998·Leukemia Research·P ZubizarretaF Sackmann-Muriel
Aug 25, 1999·British Journal of Haematology·L C RileyR F Stevens
Apr 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilmar WisplinghoffMichael B Edmond
Oct 31, 2003·Leukemia·T LehrnbecherU Creutzig
May 28, 2005·Leukemia·U CreutzigM Zimmermann
Mar 7, 2006·Annals of Hematology·Lotte AbildgaardHenrik Hasle
Dec 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kazuko KudoUNKNOWN Japanese Childhood AML Cooperative Study Group
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Aug 12, 2009·British Journal of Haematology·Thomas LehrnbecherLillian Sung
Mar 20, 2010·International Journal of Hematology·Kazuko KudoIchiro Tsukimoto
Jun 18, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H SyrjäläUNKNOWN Finnish Leukemia Group
Oct 20, 2010·British Journal of Haematology·Lene Molgaard-HansenUNKNOWN Nordic Society of Paediatric Haematology and Oncology (NOPHO)
Apr 12, 2011·Pediatric Blood & Cancer·Jeffrey W Taub, Yaddanapudi Ravindranath
May 11, 2011·Pediatric Blood & Cancer·Takashi TagaMasahito Tsurusawa
Aug 11, 2012·Blood·Ursula CreutzigUNKNOWN AML Committee of the International BFM Study Group
Sep 19, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas LehrnbecherUNKNOWN International Pediatric Fever and Neutropenia Guideline Panel
Jan 3, 2013·Pediatric Blood & Cancer·Katrine Helle JohannsenHenrik Hasle
Dec 3, 2013·Infectious Agents and Cancer·Thai Hoa TranLillian Sung
Mar 13, 2015·The Pediatric Infectious Disease Journal·Susanna FelsensteinJill A Hoffman
Jan 16, 2016·Blood Cancer Journal·K BochennekT Lehrnbecher
Citations
Mar 8, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Johann K HitzlerUNKNOWN CIBMTR Pediatric Cancer Working Committee
Dec 3, 2016·Journal of Pediatric Hematology/oncology·Kris Ann P SchultzJoseph P Neglia
Jun 24, 2017·Blood·Jessica C Shand
Apr 9, 2017·Blood·Jeffrey W TaubAlan S Gamis
Apr 13, 2017·Blood·Madita UffmannJan-Henning Klusmann
May 28, 2019·Leukemia & Lymphoma·Olga Zając-SpychałaJan Styczyński
May 21, 2020·Leukemia·Anouchka P LaurentSébastien Malinge
Jul 9, 2020·Frontiers in Pediatrics·Malgorzata CzogalaWalentyna Balwierz
Oct 20, 2020·American Journal of Medical Genetics. Part a·Stephanie L SantoroGeorge Capone
Mar 12, 2021·Pediatric Blood & Cancer·Azada IbrahimovaKelly D Getz
Apr 4, 2021·The Lancet Oncology·Thomas LehrnbecherUNKNOWN 8th European Conference on Infections in Leukaemia